HT-001

N/A

Report date: 2026/05/07 20:00:36

Base Information

Drug NameHT-001
Drug Alias NameHT-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 1 receptor antagonistsPeptide hydrolase inhibitorsVirus replication inhibitors
TargetsNeurokinin 1 receptorPeptide hydrolase
Therapy Area/IndicationsAcneiform EruptionsSkin DiseasesNeoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHoth Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHoth Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAcneiform EruptionsSkin DiseasesNeoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A